Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles

Journal of Clinical Microbiology

Volumn 38, Issue 1, 2000, Pages 99-104

  Ratnam, Samuel ^a   Tipples, Graham ^b   Head, Carol ^a   Fauvel, Micheline ^c   Fearon, Margaret ^d   Ward, Brian J ^e  

^a Newfoundland and Labrador Public Health Laboratory   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; HUMAN; MEASLES; MEASLES VIRUS; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DETECTION;

ANTIBODIES, VIRAL; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; MEASLES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UNITED STATES;

EID: 0033989511     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Agocs, M. M., L. E. Markowitz, I. Straub, and I. Dômôk. 1992. The 1988-1989 measles epidemic in Hungary: assessment of vaccine failure. Int. J. Epidemiol. 21:1007-1013.
2. Albrecht, P., K. Herrmann, and G. R. Burns. 1981. The role of virus strain in conventional and enhanced measles plaque neutralization test. J. Virol. Methods 3:251-260.
3. Centers for Disease Control. 1990. Case definitions for public health surveillance. Morbid. Mortal. Weekly Rep. 33:23.
4. Centers for Disease Control and Prevention. 1997. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. Morbid. Mortal. Weekly Rep. 46(RR-11):1-20.
5. Centers for Disease Control and Prevention. 1998. Advances in global measles control and elimination: summary of the 1997 International Meeting. Morbid. Mortal. Weekly Rep. 47:1-23.
6. de Quadros, C. A. 1997. Global eradication of poliomyelitis and measles: another quiet revolution. Ann. Intern. Med. 127:156-158.
7. de Quadros, C. A., J. M. Olivé, B. S. Hersh, M. A. Strassburg, D. A. Henderson, D. B. Bennett, and G. A. O. Alleyne. 1996. Measles elimination in the Americas. Evolving strategies. JAMA 275:224-229.
8. Erdman, D. D., L. J. Anderson, D. R. Adams, J. A. Stewart, L. E. Markowitz, and W. J. Bellini. 1991. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J. Clin. Microbiol. 29:1466-1471.
9. Gay, N., M. Ramsay, B. Cohen, L. Hesketch, P. M. Capner, D. Brown, and E. Miller. 1997. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun. Dis. Rep. CDR Rev. 7:R17-R21.
10. Helfand, R. F., J. L. Heath, L. J. Anderson, E. F. Maes, D. Guris, and W. J. Bellini. 1997. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J. Infect. Dis. 175:195-199.
11. Hummel, K. B., D. D. Erdman, J. Health, and W. J. Bellini. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:2874-2880.
12. Jin, L., A. Richards, and D. W. G. Brown. 1996. Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol. Cell. Probes 10:191-200.
13. Kambarami, R. A., K. J. Nathoo, F. K. Nkrumah, and D. J. Pirie. 1991. Measles epidemic in spite of high measles immunization coverage rates in Harare, Zimbabwe. Bull. W. H. O. 69:213-219.
14. Kobune, F., H. Sakata, and A. Sugiura. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:700-705.
15. Mayo, D. R., T. Brennan, D. P. Cormier, J. Hadler, and P. Lamb. 1991. Evaluation of a commercial measles virus immunoglobulin M enzyme immunoassay. J. Clin. Microbiol. 29:2865-2867.
16. Ozanne, G., and M.-A. D'Halewyn. 1992. Performance and reliability of the Enzygnost measles enzyme-linked immunosorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic. J. Clin. Microbiol. 30:564-569.
17. Pan American Health Organization. Update: measles in Canada, 1995. 1996. EPI Newsl. 18:3-4.
18. Ratnam, S., V. Gadag, R. West, J. Burris, E. Oates, F. Stead, and N. Bouilianne. 1995. Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J. Clin. Microbiol. 33:811-815.
19. Tipples, G. 1999. Laboratory aspects of the measles elimination program in Canada. Can. Commun. Dis. Rep. 25:45-47.
20. Working Group on Measles Elimination in Canada. 1998. Measles surveillance: guidelines for laboratory support. Can. Commun. Dis. Rep. 24:33-44.
21. World Health Organization. 1994. Expanded programme on immunization - accelerated measles strategies. Weekly Epidemiol. Rec. 69:229-234.
22. World Health Organization. 1997. EPI information system global summary, August 1997. World Health Organization, Geneva, Switzerland.